Tuberculosis spreads through germs released when a person with TB in their lungs coughs, speaks or sings. These bacteria can stay in the air for prolonged periods of time and are more likely to spread ...

Previous studies have reported the prevalence of silicosis among agate-stone workers to range from 18% to 69%, with the rate ...

A third drug, pretomanid, received emergency authorization from the FDA for specific use within a regimen against highly drug ...

The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens for drug-resistant TB. The trials are using two fairly new drugs— bedaquiline ...

Researchers identified three new all-oral drug regimens that include at least one of two new drugs for treatment of ...

Researchers analyzed global trends in multidrug-resistant tuberculosis (MDR-TB) among children and adolescents, revealing ...

TB infections have been rising every year since 2020 after 30 years of decline. Now, a historic outbreak in Kansas is ...

"Multidrug-resistant TB is a major global public health problem, affecting over 400,000 people each year. It is associated with significantly poorer outcomes than drug-susceptible TB," said ...

Tuberculosis is making headlines as the contagious respiratory disease spreads in the Midwest. Kansas is currently facing one ...

Three all-oral shortened regimens have noninferior efficacy compared with standard therapy for fluoroquinolone-suscep ...